{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P01266",
      "entity_text" : "thyroglobulin",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-1226" ],
      "Organ" : [ "uberon:UBERON:0002429" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "FDG-PET and FDG-PET/CT can help identify metastatic thyroid cancer in patients with recurrent or persistent PTC who have increased serum thyroglobulin levels and negative or equivocal whole-body iodine scans [XREF_BIBR, XREF_BIBR, XREF_BIBR].",
  "reading_complete" : "2020-08-02T17:26:32Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T17:24:32Z",
  "trigger" : "levels",
  "evidence" : [ "thyroglobulin levels" ],
  "pmc_id" : "3539949",
  "score" : 0
}